StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Xolair Global Growth in USD by Quarter

Xolair Global Growth in USD (% USD) (%)

QuarterlyAnnual

Novartis Xolair Global Growth in USD: -25.0% in Q3 2026, down 30.0 pts from a year earlier. That is the lowest of the 27 quarters on record here.

Latest, Q3 2026
-25.0%
Period ended Sep 30, 2026
Change on a year earlier
-30.0 pts
5.0% in Q3 2025
History
27 quarters
Since Q4 2018
Sources
27
Documents cited below

Where the Q3 2026 figure comes from

“|| Xolair 2 | 331 | 440 | – 25 | – 25”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedXolair Global Growth in USD (% USD) (%)Year on yearSource
Q3 2026Sep 30, 2026-25.0%-30.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026-23.0%-27.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-15.0%-29.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-4.0%-10.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20255.0%-8.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20254.0%-14.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202514.0%+1.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20246.0%-11.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202413.0%-2.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202418.0%+15.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202413.0%+17.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202317.0%+30.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202315.0%+27.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20233.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-4.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-13.0%–Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Xolair Global Growth in USD (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-xolair-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.